BlackRock Amends United Therapeutics Stake, Signals Continued Holding
Ticker: UTHR · Form: SC 13G/A · Filed: Jan 24, 2024
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investing
TL;DR
**BlackRock updated its United Therapeutics stake, still a major holder.**
AI Summary
BlackRock Inc. filed an amended SC 13G/A on January 24, 2024, indicating a change in its ownership stake in UNITED THERAPEUTICS Corp as of December 31, 2023. This amendment, the 18th for BlackRock regarding United Therapeutics, shows that BlackRock continues to be a significant institutional holder of the pharmaceutical company's common stock. This matters to investors because large institutional ownership by firms like BlackRock can signal confidence in the company's long-term prospects, but changes in their holdings can also influence stock price and market sentiment.
Why It Matters
This filing confirms BlackRock's ongoing significant institutional ownership in United Therapeutics, which can provide a level of stability and investor confidence in the stock.
Risk Assessment
Risk Level: low — This filing is a routine update from a large institutional investor and does not indicate any immediate significant risk.
Analyst Insight
Investors should note BlackRock's continued presence as a significant holder, but this routine update doesn't provide new actionable insights beyond confirming institutional interest.
Key Players & Entities
- BlackRock Inc. (company) — the reporting person and institutional investor
- UNITED THERAPEUTICS Corp (company) — the subject company whose securities are being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 24, 2024 (date) — the filing date of the SC 13G/A
- 91307C102 (other) — the CUSIP number for UNITED THERAPEUTICS Corp Common Stock
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, as stated in the 'FORM TYPE: SC 13G/A' and 'SCHEDULE 13G (Amendment No: 18)' sections.
Who is the reporting person in this filing?
The reporting person is BlackRock Inc., as indicated under the 'FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BlackRock Inc.' section.
What is the subject company whose securities are being reported?
The subject company is UNITED THERAPEUTICS Corp, as stated under 'SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp' and 'Name of Issuer: UNITED THERAPEUTICS Corp'.
What was the 'Date of Event Which Requires Filing of this Statement'?
The 'Date of Event Which Requires Filing of this Statement' was December 31, 2023, as explicitly stated in the filing.
How many amendments has BlackRock Inc. filed for UNITED THERAPEUTICS Corp's securities?
This is the 18th amendment, as indicated by '(Amendment No: 18)' on the Schedule 13G cover page.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 24, 2024 regarding UNITED THERAPEUTICS Corp (UTHR).